Skip to main navigation Skip to search Skip to main content

Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol

  • Aashna Karbhari
  • , Sherly Mosessian
  • , Kamaxi H. Trivedi
  • , Frank Valla
  • , Mark Jacobson
  • , Mark J. Truty
  • , Nandakumar G. Patnam
  • , Diane M. Simeone
  • , Elcin Zan
  • , Tracy Brennan
  • , Hongli Chen
  • , Phillip H. Kuo
  • , Ken Herrmann
  • , Ajit H. Goenka

Research output: Contribution to journal › Article › peer-review

7   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Keyphrases